Mercia Asset Management plc (AIM: MERC)

https://www.mercia.co.uk

LinkedIn: https://linkedin.com/company/mercia-asset-management

Mercia Ventures is a proactive venture capital investor focused on being the first-choice partner for growth. Mercia Ventures makes equity investments of up to £10million across all sectors, with specialisms in Software, Consumer, Healthcare and Deep Tech. Mercia Ventures is part of Mercia Asset Management PLC and sits alongside its wider private equity, debt and proprietary balance sheet capital operations. The Group has 11 offices in the UK and Mercia Ventures’ national footprint and 48 strong investment team draws on their experiences as founders, PhD scientists, software engineers, corporate financiers and management consultants to help our partner companies successfully achieve their ambitions. Mercia Asset Management PLC currently has c.£1.4billion of assets under management and, since its IPO in December 2014, has a portfolio of over 400 start-ups from pre-seed to Series B. Mercia Asset Management PLC is quoted on AIM with the epic "MERC". The Group raises its own Venture Capital Trusts (VCTs) and Enterprise Investment Scheme (EIS) Funds and details about open offers can be found through Mercia’s website. Mercia Asset Management PLC is quoted on AIM with the epic "MERC" and includes the following wholly owned subsidiaries - > Mercia Fund Management Limited is authorised and regulated by the FCA under firm reference number 524856 > Enterprise Ventures Limited is authorised and regulated by the FCA under firm reference number 183363 > EV Business Loans Limited is authorised and regulated by the FCA under firm reference number 443560 *

	Start	2019-07-05 renamed
	Group	Mercia (Group)
	Predecessor	Mercia Technologies plc (AIM: MERC)
	Industry	finance
	Industry 2	investment banking
	Person	Payton, Mark (Mercia 202402 CEO of Mercia Asset Management formerly Oxxon 200504)
	Person 2	Glanfield, Martin (Mercia Technologies 201610 CFO)

	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	17 High Street Forward House
	City	B95 5AA Henley-in-Arden
	Tel	+44-330-223-1430
		Address record changed: 2024-01-05

Basic data	Employees	C: 51 to 100 (2020-03-31)
	Currency	GBP
	Annual sales	959,000,000 (assets, managed (2022) 2022-11-22)
	Profit	-17,454,000 (2020-03-31)

		* Document for »About Section«: Newcells Biotech Ltd.. (2/14/24). "Press Release: Biotech Raises further £2.35m for Lab Models that Help Avoid Animal Testing".

		Record changed: 2024-02-19